Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Up 116.1% in February

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 6,700 shares, an increase of 116.1% from the January 31st total of 3,100 shares. Based on an average daily trading volume, of 11,500 shares, the short-interest ratio is presently 0.6 days.

Invesco Nasdaq Biotechnology ETF Price Performance

NASDAQ:IBBQ opened at $22.59 on Monday. The firm’s 50 day simple moving average is $22.17 and its 200 day simple moving average is $23.06. Invesco Nasdaq Biotechnology ETF has a one year low of $20.14 and a one year high of $24.84. The company has a market cap of $39.98 million, a PE ratio of 17.39 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Friday, December 27th. Investors of record on Monday, December 23rd were given a dividend of $0.0619 per share. The ex-dividend date of this dividend was Monday, December 23rd.

Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF

Hedge funds have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC boosted its position in Invesco Nasdaq Biotechnology ETF by 148.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock worth $604,000 after buying an additional 16,768 shares during the period. Raymond James Financial Inc. acquired a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter worth approximately $888,000. Advisory Services Network LLC boosted its position in Invesco Nasdaq Biotechnology ETF by 5.8% during the 4th quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock worth $1,154,000 after buying an additional 2,922 shares during the period. Finally, Strategic Financial Concepts LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter worth approximately $1,699,000.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.